[1]
M. E. Hale, MD, M. S. Wallace, MD, D. R. Taylor, MD, M. Kutch, MS, and S. Nalamachu, MD, “Safety and tolerability of OROS® hydromorphone ER in adults with chronic noncancer and cancer pain: Pooled analysis of 13 studies”, J of Opioid Management, vol. 8, no. 5, pp. 299–314, Sep. 2012.